VMMC
HUMA icon

V.M. Manning & Co’s Humacyte HUMA Stock Holding History

V.M. Manning & Co’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.7K Buy
+31,609
New +$29.3K 0.02% 53

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

V.M. Manning & Co's HUMA Position: Q2 2026 in Review

V.M. Manning & Co opened a new position in Humacyte (HUMA) in Q2 2026: 31,609 shares worth $24.7K. The stake represents 0.02% of the portfolio and ranks #53 among its holdings.

164 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • V.M. Manning & Co held 31,609 shares of Humacyte worth $24.7K as of Q2 2026.
  • Humacyte was a new V.M. Manning & Co position in Q2 2026.
  • Humacyte made up 0.02% of V.M. Manning & Co's portfolio in Q2 2026, its #53 holding.
  • 164 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on V.M. Manning & Co's 13F filing for Q2 2026, filed 13 Jul 2026.